Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > SiMPore Awarded Phase I SBIR From NIH To Improve TEM Imaging Technology For Biomedical Researchers

Abstract:
SiMPore Inc., an early-stage nanotechnology company in Rochester, NY, has received a Phase I SBIR grant from the National Institutes of Health to improve phase contrast transmission electron microscopy (TEM). An electron microscope uses a beam of electrons instead of light to illuminate an object of interest. It allows the object to be observed at one-million-times magnification or greater. In theory, this level of magnification should permit biomedical researchers to see the three-dimensional structure of a virus or similarly sized biological molecule. However, current TEM methods are limited in certain aspects. Phase contrast promises to overcome some of these inherent limitations of TEM imaging of biological structures.

SiMPore Awarded Phase I SBIR From NIH To Improve TEM Imaging Technology For Biomedical Researchers

Rochester, NY | Posted on September 29th, 2011

The technology that SiMPore develops will increase the practicality of phase-contrast TEM to image biological molecules. By fabricating next generation phase plates, a core component of phase-contrast TEM, SiMPore hopes to increase the practical accessibility of this method. SiMPore will apply its expertise in the fabrication of thin-films to create a new class of highly manufacturable phase plates.

The grant application elicited both high scores and favorable compliments from NIH reviewers. The reviewers unanimously acknowledged that the proposed work addresses an unmet need, is highly innovative and greatly significant. They also recognized that the proposal could have a high-degree of immediate impact on the field of electron microscopy.

Dr. Christopher Striemer, Vice-President of Membrane Development at SiMPore, said, "We believe several key factors contributed to the success of our application. Our expertise in thin-film micro-fabrication, combined with the electron microscopy expertise of our collaborator, and a clear market need for these components, provided a strong basis for our proposal. Our case was very compelling."

SiMPore will collaborate with the New York State Department of Health's Wadsworth Center, which will test the phase plates SiMPore develops. Mr. Michael Marko of the Wadsworth Center, a recognized expert in the use of phase plates, will direct the evaluation of SiMPore's prototypes. Mr. Marko has developed several first-in-class innovations in phase-contrast electron microscopy.

####

About SiMPore Inc.
SiMPore is commercializing a novel membrane technology enabling new discoveries while also reducing the time and cost of everyday development processes in the life sciences. SiMPore is a Rochester, New York-based nanotechnology company that designs and produces membranes and membrane-enabled products based on its unique patent-pending platform technology - the UltraSM« ultrathin nanoporous silicon membrane. The UltraSM« membrane is the world's first membrane to offer both tunable nanometer-scale thickness and pore size. SiMPore is developing products that take advantage of these one-of-a-kind features, including filters for separating and concentrating biological molecules and nanoparticles, cell culture substrates for growing cells, and electron microscopy grids for preparing and imaging samples at the nanoscale.

About TEMwindows.com

TEMwindows.com, a division of SiMPore Inc., is the online source of innovative sample preparation solutions for the imaging and analysis of nanoscale materials. TEMwindows.com features state-of-the-art transmission electron microscopy windows that enable researchers to characterize their cutting-edge nanomaterials. By incorporating the latest MEMS and thin film technologies, TEMwindows.com provides researchers with the resources to advance their research and development programs. TEMwindows.com is fully integrated with, and supported by, the technical expertise at SiMPore.

UltraSM is a registered trademark of SiMPore Inc.

For more information, please click here

Contacts:
Dr. Christopher Striemer
Vice-President
Membrane Development

Copyright © SiMPore Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Report highlights opportunities and risks associated with synthetic biology and bioengineering November 22nd, 2017

Quantum optics allows us to abandon expensive lasers in spectroscopy: Lomonosov Moscow State University scientists have invented a new method of spectroscopy November 21st, 2017

Nano-watch has steady hands November 21st, 2017

Nano Global, Arm Collaborate on Artificial Intelligence Chip to Drive Health Revolution by Capturing and Analyzing Molecular Data in Real Time November 21st, 2017

Imaging

The stacked color sensor: True colors meet minimization November 16th, 2017

Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs November 8th, 2017

Luleň University of Technology is using the Deben CT5000TEC stage to perform x-ray microtomography experiments with the ZEISS Xradia 510 Versa to understand deformation and strain inside inhomogeneous materials November 7th, 2017

Quorum reports on how cryo prep techniques for SEM are being applied in the Laboratory of Food Technology & Engineering at the University of Ghent, Belgium November 7th, 2017

Govt.-Legislation/Regulation/Funding/Policy

EC Project Aims at Creating and Commercializing Cyber-Physical-System Solutions November 14th, 2017

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3ĺs significant potential role in Immuno-Oncology at SITC Annual Meeting November 14th, 2017

Leti Joins DARPA-Funded Project to Develop Implantable Device for Restoring Vision November 9th, 2017

Nanoshells could deliver more chemo with fewer side effects: In vitro study verifies method for remotely triggering release of cancer drugs November 8th, 2017

Announcements

Report highlights opportunities and risks associated with synthetic biology and bioengineering November 22nd, 2017

Quantum optics allows us to abandon expensive lasers in spectroscopy: Lomonosov Moscow State University scientists have invented a new method of spectroscopy November 21st, 2017

Nano-watch has steady hands November 21st, 2017

Nano Global, Arm Collaborate on Artificial Intelligence Chip to Drive Health Revolution by Capturing and Analyzing Molecular Data in Real Time November 21st, 2017

Tools

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

Nanometrics Announces $50 Million Share Repurchase Program November 15th, 2017

Nanometrics Board of Directors Names Pierre-Yves Lesaicherre President and CEO November 14th, 2017

Oxford Instruments announces winner of the 2017 Sir Martin Wood Prize for Japan November 14th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project